Search company, investor...

Predict your next investment

Walgreens company logo
Corporation
RETAIL (NON-INTERNET/MOBILE) | Pharmacies
walgreens.com

See what CB Insights has to offer

Investments

13

Portfolio Exits

8

Partners & Customers

10

Service Providers

1

About Walgreens

Walgreens is a drugstore chain that provides multi-channel access to consumer goods and services and trusted, pharmacy, health and wellness services. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail service, along with respiratory services.

Headquarters Location

200 Wilmot Road

Deerfield, Illinois, 60015,

United States

800-925-4733

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Walgreens

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Walgreens in 3 Expert Collections, including Fortune 500 Investor list.

F

Fortune 500 Investor list

590 items

This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.

P

Pharma Supply Chain

1,277 items

H

Health Monitoring & Diagnostics

206 items

At-home IVD test developers, at-home sample collection device developers, at-home testing service providers, and all other companies playing in the at-home testing ecosystem. Companies tagged as #AtHomeTestingEcosystem

Research containing Walgreens

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Walgreens in 3 CB Insights research briefs, most recently on Nov 17, 2022.

Latest Walgreens News

Endexx Surpasses Record Annual Revenues in Fiscal First Quarter 2023

Nov 30, 2022

The Company attributes these record achievements to a combination of HYLA international purchase orders from Italy and other Western European Countries, a Central Asian nation and Dubai, as well as an increased presence for the Company’s CBD pain products and men’s skin care line, which recently began sales in 13 countries, including in the U.S., on Amazon. Combined, the two product lines are available in four of the top eight retailers in the United States, including Amazon, Walgreens, Target and CVS stores. “Our acquisition of HYLA has already exceeded our expectations, and the revenue has more than paid for our cash outlay to acquire the Company. We believe that the powerful distribution network that HYLA brought to the table, combined with our increasing presence in U.S. retail, will continue to reap benefits beyond this quarter and regularly create new record-setting opportunities,” commented Todd Davis, CEO of Endexx. “We continue to expand our market presence for all categories, and expect to provide new and exciting updates across our three product lines over the coming quarters.” About Endexx Corporation Endexx Corporation develops and distributes all natural, plant-derived topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.com Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 We caution that any forward-looking statements (as such term is defined in the U.S. Private Securities Litigation Reform Act of 1995) contained in this press release or made by us, our management, or our spokespeople involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Forward-looking statements include, without limitation, statements regarding our future operating results, the implementation and impact of our strategic plans, and our ability to meet environmental, social, and governance goals. Words such as “estimate,” “commit,” “target,” “goal,” “project,” “plan,” “believe,” “seek,” “strive,” “expect,” “anticipate,” “intend,” “potential” and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, could affect our financial performance and cause actual results to differ materially from those expressed or implied in any forward-looking statements: Except as may be required by law, we assume no obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events, even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. More information on potential factors that could affect our results is included “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2022. For further information, please contact: Endexx Corporation

Walgreens Investments

13 Investments

Walgreens has made 13 investments. Their latest investment was in Datamaran as part of their Series B on September 9, 2022.

CBI Logo

Walgreens Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/20/2022

Series B

Datamaran

$13.3M

Yes

8

5/5/2021

Series B - II

Vim

$36M

Yes

1

7/31/2019

Private Equity

Shields

Yes

2

10/4/2018

Corporate Minority

Subscribe to see more

Subscribe to see more

10

1/29/2018

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/20/2022

5/5/2021

7/31/2019

10/4/2018

1/29/2018

Round

Series B

Series B - II

Private Equity

Corporate Minority

Series C

Company

Datamaran

Vim

Shields

Subscribe to see more

Subscribe to see more

Amount

$13.3M

$36M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

8

1

2

10

10

Walgreens Portfolio Exits

8 Portfolio Exits

Walgreens has 8 portfolio exits. Their latest portfolio exit was Shields on September 21, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/21/2021

Corporate Majority

$99M

15

6/30/2020

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

1/9/2020

Management Buyout

Subscribe to see more

$99M

Subscribe to see more

10

3/4/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

1/22/2015

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/21/2021

6/30/2020

1/9/2020

3/4/2018

1/22/2015

Exit

Corporate Majority

Reverse Merger

Management Buyout

Acquired

Divestiture

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

15

10

10

10

10

Walgreens Acquisitions

12 Acquisitions

Walgreens acquired 12 companies. Their latest acquisition was AllianceRx Walgreens Pharmacy on June 24, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/24/2022

$99M

Acquired

1

7/10/2015

$99M

Acquired - II

1

11/8/2013

$99M

Acquired

2

9/19/2012

Subscribe to see more

$99M

Subscribe to see more

0

2/6/2012

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/24/2022

7/10/2015

11/8/2013

9/19/2012

2/6/2012

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Acquired

Acquired - II

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

1

2

0

10

Walgreens Partners & Customers

10 Partners and customers

Walgreens has 10 strategic partners and customers. Walgreens recently partnered with Western Union on November 11, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

11/2/2022

Partner

United States

Western Union and Walgreens Extend Collaboration Agreement

DENVER & DEERFIELD , Ill. -- -- Western Union and Walgreens Boots Alliance , Inc. today announced a renewed five-year agreement to their long-standing relationship .

2

10/31/2022

Partner

United States

1

10/26/2022

Partner

United States

Walgreens, DoorDash, Uber partner on Paxlovid delivery in underserved areas

Walgreens is partnering with DoorDash and Uber Health to deliver Paxlovid , an oral antiviral therapy for COVID-19 , to underserved communities .

1

10/25/2022

Vendor

United States

Subscribe to see more

Subscribe to see more

10

8/15/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

11/2/2022

10/31/2022

10/26/2022

10/25/2022

8/15/2022

Type

Partner

Partner

Partner

Vendor

Partner

Business Partner

Country

United States

United States

United States

United States

United States

News Snippet

Western Union and Walgreens Extend Collaboration Agreement

DENVER & DEERFIELD , Ill. -- -- Western Union and Walgreens Boots Alliance , Inc. today announced a renewed five-year agreement to their long-standing relationship .

Walgreens, DoorDash, Uber partner on Paxlovid delivery in underserved areas

Walgreens is partnering with DoorDash and Uber Health to deliver Paxlovid , an oral antiviral therapy for COVID-19 , to underserved communities .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

Walgreens Service Providers

1 Service Provider

Walgreens has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acquired

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Walgreens Team

24 Team Members

Walgreens has 24 team members, including current Chief Financial Officer, Wade Miquelon.

Name

Work History

Title

Status

Wade Miquelon

Chief Financial Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Wade Miquelon

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Financial Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare Walgreens to Competitors

Truepill Logo
Truepill

Truepill offers an online pharmacy that provides telehealth services, patient-facing brands, and solutions for health brands, pharmaceutical manufacturers, and health plan providers. The company also offers telehealth and diagnostics services alongside the company's pharmacy service. It provides a virtual pharmacy, which serves as a white-labeled pharmacy e-commerce platform for others. It caters to the pharmaceutical sector. The company was founded in 2016 and is based in Hayward, California.

Nimble Rx Logo
Nimble Rx

Nimble Rx is a pharmacy platform that enables prescriptions to be delivered the same day as prescribed to patients. The company was founded in 2014 and is based in Redwood City, California.

p
phil

Phil is a software therapy deployment platform, offering pharmaceutical manufacturers a modern alternative to traditional access, affordability and distribution options. Through its digital stakeholder experiences, patient access services, market access solutions and distribution models, pharma manufacturers are able to deliver affordable and timely therapy access to patients.

Capsule Logo
Capsule

Capsule is a pharmacy delivery service that helps users easily transfer a refill from their pharmacy to Capsule; allows doctors to e-prescribe medications; delivers directly to the user's door for free; and coordinates refills with the doctor & copays with the insurance company.

ExactCare Pharmacy Logo
ExactCare Pharmacy

ExactCare is a full-service pharmacy that specializes in medication management for patients with multiple disease states, on multiple medications. The company's pharmacy solution includes an in-home patient assessment; medication reconciliation and medication therapy management performed by clinical pharmacists; monthly refill management; customized adherence packaging; and home delivery. ExactCare's approach to pharmacy helps patients overcome the challenges of polypharmacy and health care providers and payers achieve better clinical and economic outcomes.

Favor Logo
Favor

Favor provides an online birth control prescription and delivery service to simplify access to birth control. It delivers birth control, emergency contraception, and complimentary gifts while offering a personalized and connected healthcare experience. It ensures accessibility and personal freedom while empowering women to take charge of their health and bodies. It was formerly known as The Pill Club. It was founded in 2014 and is based in San Mateo, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.